CFM Pharma is a world leader in developing unmet medical need pharmaceutical products based on organovanadium chemistry.

CFM possesses patented technology that provides a new, much-improved treatment of various acute traumatic indications such as a myocardial infarction, second-and third-degree burns, general & diabetic wounds, and other general traumatic injuries like acute kidney injury (AKI), multiple organ dysfunction syndrome (MODS) and stroke.

The company has headquarters in the Netherlands.